HB 69
An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill amends the existing Cancer Drug Repository Program Act, which currently accepts donated cancer drugs and dispenses them to indigent patients. The bill aims to streamline the program by clarifying definitions, establishing a list of approved pharmacies, and outlining procedures for restocking, dispensing, and handling donated medications. It also includes provisions for an annual report and immunity for those participating in good faith, while specifying exceptions for gross negligence or knowledge of drug contamination.
Key provisions
- Clarifies definitions related to cancer drugs, pharmacies, and healthcare facilities.
- Establishes a list of approved participating pharmacies for dispensing donated cancer drugs.
- Outlines procedures for accepting, restocking, and dispensing donated cancer drugs, including expiration date requirements.
- Provides for an annual report detailing the program's progress.
- Grants immunity to individuals and entities participating in good faith, with exceptions for gross negligence or knowledge of contamination.
- Allows temporary regulations to be adopted to facilitate program implementation, with a defined expiration period.
- Specifies eligibility criteria and procedures for both patients and participating entities.
- Addresses handling fees for pharmacies dispensing donated drugs.
Who is affected
- Cancer patients
- Pharmacies
- Healthcare facilities
- Manufacturers of cancer drugs
- The State Board of Pharmacy
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours